Please wait while we open this resource.
K
Clinical reviews
THE NEW IN ANTICOAGULATION: FACTOR XI INHIBITORS
Floraspe-Renzetti Hospital, ASL Lanciano-Vasto-Chieti; University of Pisa
PDF20234 pages221 KB
The article provides an overview of the mechanisms by which factor XI inhibitors may prevent thrombosis while preserving hemostatic function. It discusses the current landscape of direct oral anticoagulants (DOACs) and introduces new agents targeting factor XI, which are being evaluated in clinical trials. The document emphasizes the importance of these inhibitors in specific patient populations, such as those undergoing major orthopedic surgery and cancer patients at high risk for venous thromboembolism.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology